Daré Bioscience
Daré Bioscience (Nasdaq: DARE) is a San Diego-based biopharmaceutical company developing and commercializing therapies for women's reproductive and sexual health, an area of medicine it argues has been chronically underfunded relative to its size.
About Daré Bioscience
Where is Daré Bioscience headquartered?
Daré Bioscience is headquartered in San Diego, CA.
What does Daré Bioscience do?
Daré Bioscience (Nasdaq: DARE) is a San Diego-based biopharmaceutical company developing and commercializing therapies for women's reproductive and sexual health, an area of medicine it argues has been chronically underfunded relative to its size.
What problem does Daré Bioscience solve?
Women's reproductive and sexual health has historically received a small share of biopharmaceutical R&D investment relative to other therapeutic areas, leaving real gaps in approved treatment options.
What's Daré Bioscience's solution?
A multi-product pipeline spanning contraception, vaginal health, and sexual health, including its first FDA-approved product, Xaciato, and DARE to PLAY, a sildenafil cream moving toward prescription dispensing.
What makes Daré Bioscience different?
One of the few publicly traded, pure-play women's health biopharmaceutical companies (Nasdaq: DARE), with an FDA-approved product already on the market rather than only a pipeline of candidates still in trials.
What makes Daré Bioscience notable?
Female-led and founded in 2015 by CEO Sabrina Martucci Johnson; has invested more than $200 million in women's health R&D and holds one FDA-approved product (Xaciato, for bacterial vaginosis) alongside five completed clinical trials submitted to the FDA.
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 11, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
